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Group A streptococcal (S. pyogenes; GAS) infection is endemic in the Northern 
Territory of Australia, and the rates of invasive GAS disease and post-infection sequelae 
are among the highest reported in the world. Plasminogen is a potent human protease 
sequestered to the GAS cell-surface by plasminogen and fibrinogen receptors and 
activated by GAS streptokinase and host plasminogen activators. The critical role of 
plasminogen in GAS invasion was recently demonstrated in a human plasminogen 
transgenic mouse model of infection.  
 
The aim of this study was to determine whether plasminogen is deployed as a virulence 
factor in invasive GAS disease, with particular reference to the Northern Territory of 
Australia. This question was first approached from an epidemiological perspective, 
comparing Northern Territory GAS isolates from invasive infections with those from 
uncomplicated infections for their interaction with the plasminogen system.  
Plasminogen binding; plasminogen receptor expression and genetic variation; 
fibrinogen binding; streptokinase expression, activity and genetic variation; 
streptococcal pyrogenic exotoxin B (SpeB) expression and activity; and acquisition of 
cell-surface plasmin in human plasma were characterised for 29 GAS isolates of known 
clinical origin from the Northern Territory. The second approach to determining the role 
of plasminogen in invasive disease in the Northern Territory was to investigate GAS 
infection using a human plasminogen transgenic mouse model. A subset of Northern 
Territory GAS isolates selected for different in vitro plasminogen activation 





This study revealed that Northern Territory GAS isolates from invasive disease cases 
acquire more plasminogen than isolates from uncomplicated infections, however they 
do not produce more streptokinase nor acquire more cell-surface plasmin after 
incubation in human plasma in vitro. Presence of the gene for the plasminogen-binding 
group A streptococcal M-like protein (PAM) conferred upon GAS isolates a strikingly 
different profile of interaction with plasminogen, characterised by higher plasminogen 
binding and plasmin acquisition in plasma. Differences in the catalytic specificity of 
streptokinase secreted by pam-positive and pam-negative isolates were identified and 
their allelic determinants investigated. A new model of GAS cell-surface plasminogen 
activation is proposed for pam-positive isolates. To characterise the role of 
streptokinase and the cysteine protease SpeB in acquisition of cell-surface plasmin 
activity in human plasma, such acquisition was compared in GAS deletion mutants for 
genes encoding these proteins and the corresponding wildtype strains. The dramatic 
reduction of GAS cell-surface plasmin activity by SpeB may significantly disable GAS 
invasive potential. Infection studies in the human plasminogen transgenic mouse model 
revealed the critical role of plasminogen in virulence of some Northern Territory 
isolates, however in vitro plasminogen activation characteristics do not predict clinical 
phenotype nor virulence in the transgenic mouse model. The results suggest an 
important and complex interaction between plasminogen and other host and/or bacterial 
factors in establishing invasive GAS infection in the Northern Territory of Australia. 
